
Leber Congenital Amaurosis 15: Lighting the Path with Genetic Testing
NMNAT1 keeps retinal photoreceptors working; mutations let those cells degenerate and sight is lost early. Counseling and testing are described.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

NMNAT1 keeps retinal photoreceptors working; mutations let those cells degenerate and sight is lost early. Counseling and testing are described.

RPGRIP1 mutations disrupt retinal photoreceptors, bringing nystagmus, severe vision impairment and trouble seeing in low light from birth.

GUCY2D is often implicated in this retinal dystrophy, which causes vision loss from birth; confirming the mutation guides counseling and trial access.

A novel CRB1 variant ties LCA8 to retinal damage present from birth. Testing, family planning and experimental CRISPR-Cas9 work are covered.

Explore LEOPARD Syndrome 3, a rare genetic disorder, and discover how genetic testing aids in diagnosis, family planning, and personalized treatment strategies.

Faulty potassium flow through the KCNH2 channel stretches the QT interval; the page sets out beta-blockers, defibrillators, relative screening and genetic counseling.

Fainting or palpitations brought on by stress or exercise can signal LQT5, which traces to KCNE1 mutations; testing guides beta-blockers and lifestyle changes.

LQT6 traces to KCNE2 mutations that slow the heart's electrical recovery, lengthening the QT interval; testing identifies carriers before symptoms appear.